The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model
Hiroaki Ohno, Yasunori Uemura, Hideko Murooka, Hiromi Takanashi, Takemi Tokieda, Yumiko Ohzeki, Kazuo Kubo, Isao SerizawaVolume:
38
Year:
2008
Language:
english
Pages:
9
DOI:
10.1002/eji.200737199
File:
PDF, 368 KB
english, 2008